Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Cost-effectiveness of Inpatient Tympanostomy Prophylaxis
Heather Yeakel
, Luke J. Pasick
, Gregory J. Kirchner
, Brian J. McKinnon
, Rebecca C. Chiffer
Otolaryngology
Research output
:
Contribution to journal
›
Article
›
peer-review
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cost-effectiveness of Inpatient Tympanostomy Prophylaxis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Agents Acting on the Auditory and Vestibular Systems
40%
Ambulatory Surgery
10%
Ciprofloxacin
100%
Cost-Effectiveness Analysis
100%
Dexamethasone
70%
Dexamethasone Sodium Phosphate
30%
Health Care Cost
90%
Infection Rate
20%
Observational Study
10%
Ofloxacin
70%
Otorrhea
30%
Outpatient
70%
Pediatrics
10%
Risk Reduction
80%
Tympanostomy
100%
Keyphrases
Absolute Risk Reduction
80%
Break-even Analysis
10%
Ciprofloxacin
100%
Cost-effectiveness
100%
Economic Model
10%
High Cost
10%
Infection Rate
20%
Initial Infection
10%
Ofloxacin
70%
Otic
40%
Otorrhea
30%
Outpatient Treatment
70%
Pediatric Ambulatory Surgery
10%
Tympanostomy
100%
Pharmacology, Toxicology and Pharmaceutical Science
Agents Acting on the Auditory and Vestibular Systems
40%
Ciprofloxacin
100%
Dexamethasone
70%
Dexamethasone Sodium Phosphate
30%
Infection Rate
20%
Observational Study
10%
Ofloxacin
70%
Otorrhea
30%